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Ethnopharmacological relevance: Although Echinodorus grandiﬂorus, Cuphea carthagenensis, and Phyl-
lanthus tenellus infusions are used in Brazilian folk medicine due to their possible diuretic effect, none of
these species was critically investigated as a diuretic drug. So, the aim of this study was to evaluate the
possible acute diuretic activity of ethanol soluble fractions (ES) obtained from these species and assess
the relationship between renal cortical blood ﬂow and their antioxidant and hypotensive activity using
normotensive Wistar rats.
Material and methods: The preparation obtained from E. grandiﬂorus (ES-EG), C. carthagenensis (ES-CC),
and P. tenellus (ES-PT) infusions was orally administered in a single dose to rats. Urine excretion rate, pH,
density, conductivity and Naþ , Kþ , Cl and HCO3 contents were measured in the urine of saline-loaded
animals. Concentration of electrolytes, total protein, urea, creatinine, and angiotensin converting enzyme
(ACE) activity were evaluated in collected serum. The involvement of the renal cortical blood ﬂow and
antioxidative activity in the hypotensive and diuretic effects was also determined.
Results: Water and Naþ , Cl and Naþ excretion rates were signiﬁcantly increased by ES-EG, while ur-
inary bicarbonate excretion was reduced. Moreover, ES obtained from E. grandiﬂorus was able to sig-
niﬁcantly increase renal blood ﬂow and reduce mean arterial pressure and oxidative stress in “in vitro”
and “in vivo” models. All other parameters evaluated were not affected by any treatment.
Conclusion: The results presented here shown that the ES-EG obtained from E. grandiﬂorus leaves shown
a signiﬁcant diuretic and hypotensive activity and suggest that these effects could be related with an
important renal and systemic vasodilator effect. In addition, it was shown for the ﬁrst time that the
pharmacological effects of ES obtained from P. tenellus and C. carthagenensis do not support its popular
use as a diuretic agent.
& 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The World Health Organization (WHO) estimates that high
blood pressure (hypertension) is responsible for at least 45% ofrved.
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ourados, Rodovia Dourados-
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a e Biologia Molecular, Uni-
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ior).deaths due to heart diseases, and 51% of deaths due to stroke
worldwide (WHO, 2013). Moreover, approximately 40% of adults
aged 25 and above had been diagnosed with hypertension; the
number of people with the condition rose from 600 million in
1980 to 1 billion in 2008, classifying hypertension as one of the
most important global public health problems (WHO, 2011).
Hypertension prevention and control is complex and requires
the engagement of patients, families, providers, healthcare sys-
tems and communities. This includes expanding patient and
healthcare provider awareness, changing lifestyles (healthy diet,
avoiding harmful use of alcohol, physical activity, stopping tobacco
use, and stress management), high level of medication adherence,
and adequate follow-up (Chobanian et al., 2003; Lloyd-Jones et al.,
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Studies have shown that a substantial proportion of hy-
pertensive patients do not have controlled blood pressure levels,
and the major reason is the poor adherence to antihypertensive
medications (Borzecki et al., 2005). Older age, living alone, and
perception related to treatment control were signiﬁcant in-
dependent factors associated with better medication adherence.
Moreover, cultivating positive beliefs that hypertension is con-
trolled by treatment is one of the most appropriate ways for
adequate control of this pathology (Marshall et al., 2012).
In this context, the socio-cultural appeal from medicinal plants,
transferred by generations, translates an idea of reliability and
safety of these herbal remedies, contributing to improve the
therapeutic arsenal and helping adherence to antihypertensive
medications. Thus, the popular culture is used in the identiﬁcation
of medicinal native species that can contribute to conventional
treatment and encourage the belief that hypertension control is
possible and might provide additional beneﬁt.
In South America, several natural products are used as anti-
hypertensive agents primarily due to their diuretic activity.
Nevertheless, very few native species have been critically in-
vestigated despite the immense biodiversity available in these
countries. As an example, throughout South America, and espe-
cially in Brazil, Echinodorus grandiﬂorus (Cham. and Schltr.) Mi-
cheli, Cuphea carthagenensis (Jacq.) J.F. Macbr., and Phyllanthus te-
nellus Roxb. are widely used as diuretic, hypotensive and anti-
hypertensive drugs. Nevertheless, these species require a thorough
ethnopharmacological investigation due to their extensive popular
use as diuretics (Vendruscolo and Mentz, 2006; Lorenzi and Matos,
2008; Bolson et al., 2015).
E. grandiﬂorus (Alismataceae) is an endemic species of Brazil. It
is popularly known as “chapéu de couro” and it sporadically grows
on various humid soils as support vegetative cover. The parts used
as medicine are leaves that are habitually used as a hot water
infusion orally administered. Traditionally, this plant has been
used as diuretic, hypotensive, in the prevention of arteriosclerosis,
depurative, anti-inﬂammatory and analgesic (Lorenzi and Matos,
2008; Brugiolo et al., 2009; Bolson et al., 2015). This species have
been shown to contain several fatty acids, diterpenoids, phenolic
acids, ﬂavonols, alkaloids, saponins and tannins (Brugiolo et al.,
2009; Garcia et al., 2010). Several pharmacological studies per-
formed with different extracts from the leaves of E. grandiﬂorus
have shown anti-inﬂammatory and analgesic (Dutra et al., 2006),
antihypertensive (Lessa et al., 2008), vasodilator (Tibiriçá et al.,
2007), antimicrobial (Souza et al., 2004) and immunosuppressive
effects (Pinto et al., 2007).
C. carthagenensis (Jacq.) J.F. Macbr. is a medicinal plant be-
longing to family Lythraceae, and popularly known in Brazil as
“sete sangrias”. This species is found throughout South America,
especially in the southern states of Brazil. The leaves of this plant
are recommended in folk medicine to promoting and treating
various diseases including fever, constipation, edemas, hyperten-
sion, atherosclerosis and circulatory disorders (Vendruscolo and
Mentz, 2006; Lorenzi and Matos, 2008). Some constituents of this
plant were detected to be triterpenes such as carthagenol (Gon-
zález et al., 1994), tannins, proanthocyanidins, and ﬂavonoids, in-
cluding quercetin and their glycosylated derivatives (Krepsky et al.,
2010, 2012).Recent pharmacological studies have shown that the
crude extract obtained from this species was able of inhibit the in
vitro activity of the angiotensin converting enzyme (ACE) (Braga
et al., 2000), and induce arterial vasodilation in rat aorta pre-
parations (Schuldt et al., 2000; Krepsky et al., 2012). Moreover, the
hypocholesterolemic effect (Biavatti et al., 2004) and radical sca-
venger activities of the crude extract and fractions obtained from
C. carthagenensis have also been reported (Schuldt et al., 2004).
P. tenellus Roxb. (Phyllantaceae) is an herbaceous plant thatoccurs practically throughout the Brazilian territory and is popu-
larly known as “quebra pedras”. This species is widely used in
Brazilian traditional or folk medicine as a diuretic and are also
indicated in the treatment of jaundice, hepatitis, kidney stones and
diabetes (Calixto et al., 1998; Bolson et al., 2015; Tribess et al.,
2015). Previous phytochemical studies conducted with P. tenellus
leaves have demonstrated the presence of various polyphenolic
compounds such as condensed tannins, ﬂavonoids and lignans
(Calixto et al., 1998; Huang et al., 2003; Sprenger and Cass, 2013).
Preclinical studies have shown positive effects in the treatment of
hepatitis and urolithiasis (Calixto et al., 1997). In addition, antiviral
(Shead et al., 1992), antibacterial (Oliveira et al., 2007), and an-
algesic effects (Santos et al., 1994) have also been reported.
The aim of this work was to determine the pharmacological
rationale for the empirical use of E. grandiﬂorus, C. carthagenensis,
and P. tenellus as diuretic agents. The present study represents the
ﬁrst study to investigate the diuretic properties of a water infusion
obtained from these species and relate this pharmacological ac-
tivity with the effects on renal cortical blood ﬂow in Wistar rats.2. Materials and methods
2.1. Drugs
Hydrochlorothiazide (HCTZ) was obtained from Sigma-Aldrich
(St. Louis, MO, USA). Sodium chloride was obtained from Merck
(Darmstadt, Germany). All other reagents were obtained in ana-
lytical grade.
2.2. Phytochemical study
2.2.1. Plant material
The aerial parts of C. carthagenensis and P. tenellus and leaves of
E. grandiﬂorus were collected in February, 2014 from the botanical
garden of the Universidade Paranaense (UNIPAR) (Umuarama,
Brazil) at 430 m altitude above sea level (S23°47′55–W53°18′48).
A voucher C. carthagenensis and P. tenellus specimens are cataloged
in the Herbarium of the Universidade Paranaense (HEUP) under
number 2403 and 2401, respectively. E. grandiﬂorus was cataloged
in the Herbarium of the Universidade Estadual de Maringá
(HUEM) under number 20810.
2.2.2. Preparation of aqueous extracts
The plant material was air-dried in an oven at 37 °C for 5 days,
and then cut and pulverized. The extracts were obtained by infu-
sion in a similar manner to that used popularly in Brazil (Bolson
et al., 2015). 1 L of boiling water was poured over 60 g of dried
ground leaves; the container was closed, and the extraction was
allowed to proceed until room temperature was reached (6 h).
The infusion extract was treated with 3 volumes of EtOH, which
gave rise to a precipitate and an ethanol soluble fraction (ES). All
preparations were freeze-dried and maintained at room tem-
perature until analyses. The aerial parts of C. carthagenensis and P.
tenellus yielded 16% and 15%, respectively, whereas E. grandiﬂorus
leaves yielded 13%.
2.2.3. Sample analysis (liquid chromatography–mass spectrometry)
The samples were examined by ultra-high performance liquid
chromatography (UPLC™-Acquity, Waters Co., São Paulo, Brazil)
composed by a binary pump and a photodiode array (PDA) de-
tector. Samples at 2 mg/mL concentration were prepared in H2O–
MeOH (7:3 v/v) and the analysis was carried out on a reversed-
phase HSS-C18 column (2.1100 mm2 with 1.7 mm of particle
size, Waters Co.). The binary solvent was composed of (A) 0.1%
aqueous formic acid (v/v) and (B) methanol. The linear solvent
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creasing solvent percentage (B) from 0% to 38% at 10 min, then to
60% at 13 min and returning to initial condition at 14 min, re-
equilibrated for 3 min (Carlotto et al., 2015). The column was he-
ated at 60 °C and samples kept at room temperature (22 °C). The
injection volume was 2 mL and compounds were detected at λ
200–400 by high resolution mass spectrometry (HR-MS).
HR-MS analyses were developed on an electrospray ionization
mass spectrometry (ESI-MS) LTQ-Orbitrap-XL (Thermo-Scientiﬁc,
Waltham, USA), operating in the negative ionization at atmo-
spheric pressure ionization (API). The source temperature was
350 °C and N2 streamwas used for sample desolvation with sheath
gas ﬂow rate at 60 arbitrary units (abu) and auxiliary at 20 abu.
The ionization parameters were: spray voltage of 3.5 kV, capillary
of 20 V and tube lens of 130 V. For mass accuracy, external
calibration was performed (100–2000m/z) and resolution was set
at 30,000 FWHM (at m/z 400) in LC–MS mode. Acquisition was
obtained in total ion current (TIC) mode, with mass range of m/z
100–1000. Compound fragmentation was obtained by collision-
induced dissociation (CID) using helium and energy of 20 eV.
2.3. Pharmacological tests
2.3.1. Animals
Male Wistar rats (250–300 g) were used in experiments. The
animals were provided by Federal University of Paraná (UFPR,
Curitiba/PR, Brazil), and kept at temperature- and light-controlled
room (2272 °C; 12-h light/dark cycle) with free access to water
and food. All experimental procedures adopted in this study were
previously approved by the Institutional Ethics Committee of
Universidade Paranaense (UNIPAR, Brazil; protocol number 25454/
2014).
2.3.2. Acute diuretic activity
The diuretic activity assessment was performed according to
methods previously described (Kau et al., 1984) with some mod-
iﬁcations (Gasparotto Junior et al., 2009). Rats were fasted over-
night (12 h) with free access to water. Before treatments, all ani-
mals received an oral load of isotonic saline (0.9% NaCl, 5 mL/
100 g) to impose a controlled water and salt balance. Subse-
quently, different groups of rats were orally treated with ES-EG
(30, 100 or 300 mg/kg),ES-PT (30, 100 or 300 mg/kg), ES-CC (30,
100 or 300 mg/kg), or HCTZ (10 mg/kg). Control rats received the
same volume of deionized water, the vehicle used to dissolve the
extracts. Immediately after treatment, rats were placed in meta-
bolic cages. Urine was collected in a graduated cylinder and its
volume was recorded for 8 h (expressed as mL/100 g). At the end
of the experimental period, animals were sacriﬁced and their
blood was collected for biochemical analysis.
2.3.2.1. Analytical procedures. For serum analysis, blood samples
were collected in conical tubes after decapitation. Plasma and
serum were obtained by centrifugation (2000 rpm, 10 min, 4 °C),
and stored at 20 °C until analysis. Urinary and plasmatic Naþ
and Kþ levels were quantiﬁed by Q398112 ﬂame photometry
(Quimis Instruments, Diadema, Brazil). Cl and HCO3 con-
centrations were quantiﬁed by titration. pH and conductivity were
directly determined on fresh urine samples using Q400MT pH-
meter and Q795M2 conductivity meter (Quimis Instruments,
Diadema, Brazil), respectively. Density was estimated by weighing
with a Mettler AE163 (70.1 mg) analytical scale of urine volume
measured with a Nichiryo micropipette. Plasma total protein, urea
and creatinine concentrations were determined by enzymatic
method using BM/Hitachi 912 automated analyzer (Cobas Mira,
Roche, Indianapolis, USA). Serum Angiotensin Converting Enzyme
(ACE) activity was measured by methods previously described(Santos et al., 1985). Additionally, excretion load (El) of sodium,
potassium, chloride and bicarbonate was obtained according to
the equation below (1):
U VEl 1x= × ( )
Ux: Electrolytes concentration (mEq/L)
V: Urinary ﬂow (mL/min)
Results were expressed as μEq/min/100 g
2.3.3. Hemodynamic study
2.3.3.1. Direct Blood pressure and heart rate measurement.
Normotensive male Wistar rats were anesthetized with ketamine
(100 mg/kg) and xylazine (20 mg/kg), intramuscularly adminis-
tered and supplemented at 45–60 min intervals. A polyethylene
catheter was inserted into the right femoral vein for drug ad-
ministration. Immediately after venous cannulation, a bolus in-
jection of heparin (30 IU) was i.v administered. Animals were al-
lowed to breath spontaneously through a tracheotomy. The left
carotid artery was cannulated and connected to a pressure trans-
ducer coupled to a PowerLabs recording system, and an applica-
tion program (Chart, v 4.1; all from ADI Instruments; Castle Hill,
Australia) recorded both mean arterial pressure (MAP) and heart
rate (HR) (Gasparotto Junior et al., 2011). After this procedure,
different groups of rats received ES-EG (30, 100 or 300 mg/kg), ES-
PT (30, 100 or 300 mg/kg), or the ES-CC (30, 100 or 300 mg/kg)
intraduodenally. The control group received vehicle in-
traduodenally at a constant volume of 100 mL/100 g of body
weight. The changes in MAP and HR were recorded for 45 min
after treatments. Each animal received only one of the substances
studied. At the end of experiments, animals were sacriﬁced with
an overdose of thiopental (over 40 mg/kg, i.v.).
2.3.3.2. Renal cortical blood ﬂow (RCBF). Renal cortical blood ﬂows
were measured according to previous methods (Flemming et al.,
2000). After preparation for PAM measurement (as described
above), a standard plastic tube (DP2b, Moor Instruments, Axmin-
ster, UK) was placed on the ventral surface of the kidney (renal
capsule below 2 mm) coupled to a PowerLabs recording system,
and an application program (Chart, v 4.1; all from ADI Instru-
ments; Castle Hill, Australia). This system measures tissue perfu-
sion by the number of cells moving and their mean velocity within
an area of 1 mm3 beneath the tip of each probe. The laser-Doppler
signal (LDS) is independent of the cell movement direction. After
this procedure, different groups of rats received ES-EG (30, 100 or
300 mg/kg), ES-PT (30, 100 or 300 mg/kg), ES-CC (30, 100 or
300 mg/kg) or vehicle intraduodenally, at constant volume of
100 mL/100 g of body weight. The changes in RCBF were recorded
for 45 min after treatments. Each animal received only one of the
substances studied. Proper location of the optical ﬁbers within the
kidney was veriﬁed at the end of the experiment by inspecting the
location of the ﬁber tips.
2.3.4. Oxidative stress scavenger assays
2.3.4.1. DPPH radical scavenging activity. The method of capturing
2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical was used to
determine the antioxidant activity as described by Gupta and
Gupta (2011) with some modiﬁcations. Various ES-EG, ES-PT or ES-
CC (1000, 500, 100, 50, 25, 10, 5, 1 and 0.1 mg/mL) concentrations
were homogenized in 1.8 ml of a methanol DPPH solution
(0.11 mM). Reading was performed using spectrophotometer at
wavelength of 517 nm after 30 min incubation with and without
light room temperature. Antioxidant ascorbic acid was used as a
standard at the same concentrations as the extract. Methanol was
used as blank. IC 50 values were calculated from the regression
equation prepared for the different concentrations of both
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2.3.4.2. Hemolytic activity and protection against 2,29 –Azobis (2-
amidinopropane) dihydrochloride (AAPH)-induced hemolysis.
Protection against lipid peroxidation was assessed by the hemo-
lysis protection method induced by AAPH described by Valente
et al. (2011). A solution of 10% erythrocytes was prepared in saline
(He) and pre-incubated at 37 °C for 30 min in the presence of
different ascorbic acid, ES-EG, ES-PT or ES-CC (1000, 300, 100, 30,
10 μg/mL) concentrations. Then, 50 mM AAPH solution was added.
Total hemolysis was induced by incubating He with distilled water.
Basal hemolysis caused by aqueous extract (ES) was assessed by
incubating He with the extract without the presence of a hemo-
lysis inducer, and the negative control was assessed in He in-
cubated only with 0.9% NaCl. After adding AAPH, aliquots were
collected at 60, 120, 180 and 240 min and read at 540 nm. Three
independent experiments were performed in triplicate.
2.3.4.3. Nitric oxide radical assay. Quantitative measurements of
the nitric oxide radical scavenging property were carried out using
the Griess Illosvoy reaction (Kumar et al., 2008). ES-EG, ES-PT and
ES-CC at various concentrations (1000, 300, 100, 30, 10 μg/mL)Fig. 1. UPLC analysis of ES obtained from Echinodorus grandiﬂoruwere mixed with 2 mL sodium nitroprusside (10 mM) in standard
phosphate saline buffer (50 mM, pH 7.4) and incubated at room
temperature for 3 h. After the incubation period, samples were
diluted with of 0.5 mL of Griess reagent. The absorbance of the
color developed during nitrite diazotization with sulfanilamide
and its subsequent coupling with N-(1-Naphthyl) ethylenediamine
dihydrochloride was measured at 550 nm on spectrophotometer.
Ascorbic acid was used as standard. IC50 values were calculated
from the regression equation prepared for the different aqueous
extract concentrations.
2.3.4.4. Serum nitrate/nitrite determination (NOx). Plasma nitrite
concentration was determined by enzymatically reducing nitrate
using nitrate reductase enzyme (Schmidt et al., 1989). After eva-
luation of the acute diuretic activity (8 h after treatments), plasma
samples were collected from rats, deproteinized with zinc sulfate
(30 mmol) and diluted at 1:1 with Milli-Q water. For the conver-
sion of nitrate into nitrite, samples were incubated at 37 °C for 2 h
in the presence of nitrate reductase expressed in Escherichia coli.
After the incubation period, samples were centrifuged (800g,
10 min) to remove bacteria. Then, 100 mL of supernatant were
mixed with an equal volume of Griess reagent (1% sulfanilamide ins (A), Phyllanthus tenellus (B), and Cuphea carthagenensis (C).
Table 1
Effect of acute oral administration of ethanol soluble fractions (ES) obtained from Echinodorus grandiﬂorus (ES-EG), Phyllanthus tenellus (ES-PT) and Cuphea carthagenensis
(ES-CC) on urinary volume, pH, conductivity and density.
Group Urine volume (8 h/100 g) pH Conductivity (mS/cm) Density (g/mL)
Control 3.270.3 6.670.2 15.470.2 101370.3
HCTZ (25 mg/kg) 6.670.4a 6.770.1 17.270.1a 100970.6
ES-EG (30 mg/kg) 4.470.2 6.270.2 15.270.1 101370.6
ES-EG (100 mg/kg) 4.670.2a 6.470.3 15.970.1 101370.7
ES-EG (300 mg/kg) 5.470.3a 6.370.3 16.870.2a 101271.4
ES-PT (30 mg/kg) 3.070.2 6.470.1 14.670.1 101071.2
ES-PT (100 mg/kg) 3.270.2 6.470.2 15.570.2 101171.2
ES-PT (300 mg/kg) 3.170.3 7.170.2 15.070.2 101271.0
ES-CC (30 mg/kg) 4.170.7 6.670.2 15.170.2 101271.3
ES-CC (100 mg/kg) 3.570.6 6.970.1 14.970.3 101071.2
ES-CC (300 mg/kg) 3.870.6 6.770.1 15.370.3 101171.3
Values are expressed as mean7S. E. M. of ﬁve rats in each group in comparison with the control using one-way ANOVA followed by Dunnet test.
a po0.05.
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Milli-Q water) in a 96-well plate and read at 540 nm in a plate
reader. Standard nitrite and nitrate curves (0–150 mM) were si-
multaneously performed.
2.3.5. Statistical analysis
Results are expressed as mean7standard error of the mean of
ﬁve animals in each group. Statistical evaluation was carried out
by analysis of variance (ANOVA) followed by Dunnett’s test. P-
value less than 0.05 was considered statistically signiﬁcant. Graphs
were drawn and statistical analysis was carried out using the
GraphPad Prism software version 5.0 for Mac OS X (GraphPad
Software, San Diego, CA, USA).3. Results
3.1. Phytochemical characterization
ES-EG obtained from E. grandiﬂorus was analyzed by LC–MS,
resulting in a great variety of phenolic compounds, mainly ﬂavo-
noids C-glycosides (Fig. 1A), which were conﬁrmed by collision
induced dissociation (CID-MS) analysis, being in accordance with
previous ﬁndings (Schnitzler et al., 2007; Garcia et al., 2010). The
presence of this compounds was conﬁrmed by HR-MS, which gave
negative ions consistent with mono-C-ﬂavonoids, such as iso-
orientin at m/z 447.09322 (Rt 8.73), swertiajaponin at m/z
461.10884 (Rt 8.96), isovitexin at m/z 431.09826 (Rt 9.72), swerti-
sin at m/z 445.09322 (Rt 10.01) and isoorientin-dimethylether at
m/z 475.12439 (Rt 10.36). Flavonoids di-C-glycosides, such as iso-
orientin-rhamonoside at m/z 593.15120 (Rt 8.91), isoorientin-
rhamnoside-dimethylether at m/z 621.18254 (Rt 10.53), isovitexin-
pentoside atm/z 563.14049 (Rt 8.60), swertiajaponin-rhamonoside
at m/z 607.16684 (Rt 10.26), isovitexin-rhamonoside at m/z
577.15633 (Rt 9.86), and swertisin-rhamnoside at m/z 591.17193
(Rt 10.22) were also present in this extract. At lower abundance,
feruloyl-tartaric acid (m/z 325.05639, Rt 5.71) and diferuloyl-tar-
taric acid (m/z 501.10380, Rt 10.91 and 11.49) also appeared in the
extract.
LC–MS analysis of ES-PT obtained from P. tenellus showed the
presence of several hydrolysable tannins and some ﬂavonoids
glycosides (Fig. 1B). HR-MS analysis revealed the presence of
several ellagitannins at m/z 913.19088 (Rt 4.77), m/z 969.08769 (Rt
7.67), and m/z 923.08140(Rt 10.99), and hexahydroxydiphenoyl-
glucopyranoside isomers at m/z 633.06710 (Rt 2.28), m/z
633.06560 (Rt 2.79) and m/z 633.07358 (Rt 6.44), which had si-
milar fragments on CID-MS analysis. Flavonoids glycosides such as
myricetin-rhamnoside (myricetrin) at m/z 463.08803 (Rt 9.30),quercetin-rutinoside m/z 609.14631 (Rt 9.80), and kaempferol-
rutinoside m/z 593.15153 (Rt 10.88) were also observed. This
composition is in accordance with Sprenger and Cass (2013).
On the other hand, ES-CC analysis revealed the abundant pre-
sence of free ﬂavonoids such as quercetinm/z 301.03555 (Rt 10.04)
and glycosides, such as quercetin-hexoside m/z 463.08808 (Rt
9.21), quercetin-hexosyl-rhamnoside m/z 609.14593 (Rt 9.87),
quercetin-pentoside m/z 433.07756 (Rt 10.55) and kaempferol-
rutinoside m/z593.15112 (Rt 10.99) (Fig. 1C). Moreover, the pre-
sence of citric acid at m/z 191.01965 (Rt 0.96) was observed. The
major peak at 9.73 min gave the ion at m/z 477.06754 with a main
fragment on CID-MS at m/z 301.033, consistent with quercetin, but
linked to an unknown group.
3.2. ES obtained from Echinodorus grandiﬂorus induces diuresis,
natriuresis and increases renal cortical blood ﬂow in normotensive
Wistar rats
Treatment with a single dose of ES-EG (100 and 300 mg/kg)
signiﬁcantly increased diuresis after 8 h (Table 1). The total volume
of urine measured at 8 h in ES-EG-treated animals was 4.670.2
and 5.470.3 mL/100 g, respectively; while the urinary volume
observed in the control group at this same time was 3.270.3
(po0.05). The cumulative urinary volume found in ES-EG -treated
animals (100 and 300 mg/kg) was not different from that obtained
in animals treated with HCTZ.
The effects of acute treatment of ES-EG (30, 100 and 300 mg/
kg) on electrolyte excretion in urine collected at 8 h after treat-
ments are presented in Table 2. Excreted sodium, potassium and
chloride load was signiﬁcantly increased in groups treated with
ES-EG (100 and 300 mg/kg) when compared to controls treated
with vehicle alone. Similarly, urine conductivity was signiﬁcantly
increased after treatment with the ES-EG at a dose of 300 mg/kg.
Moreover, ES-EG presented an interesting sparing effect on bi-
carbonate in at all doses used, while group treated with hydro-
chlorothiazide showed high amounts of this electrolyte in the
urine. All other urinary (pH and density; Table 1) or serum para-
meters (sodium, potassium, urea, creatinine, total protein, and ACE
activity) showed no signiﬁcant differences when compared to the
control group.
In addition to the above data, a signiﬁcant increase in renal
cortical blood ﬂow was observed after acute administration of ES-
EG (100 and 300 mg/kg). The data showed an increase ranging
from 12.5% to 25% respectively, when compared to groups treated
with vehicle alone (Fig. 2A).
3.3. ES obtained from Cuphea carthagenensis and Phyllanthus te-
nellus was not able to induce any changes in renal function or cortical
Table 2
Effect of acute oral administration of ethanol soluble fractions (ES) obtained from Echinodorus grandiﬂorus (ES-EG), Phyllanthus tenellus (ES-PT) and Cuphea carthagenensis
(ES-CC) on urinary electrolyte excretion.
Group ElNaþ (lEq/min/100 g) Elkþ (lEq/min/100 g) ElCl (lEq/min/100 g) ElHCO3 (lEq/min/100 g) Saluretic indexb
Naþ Kþ Cl HCO3
Control 0.7670,07 0.2770,02 1.5170.21 0.1270.03 – – – –
HCTZ (10 mg/kg) 1.7370.14a 0.6370.08a 3.9570.24a 0.3270.02a 2.27 2.33 2.61 2.66
ES-EG (30 mg/kg) 0.6970.09 0.2570.03 2.2670.16a 0.1570.02 0.90 0.92 1.49 1.25
ES-EG (100 mg/kg) 1.3070,06a 0.2470.02 2.3970.16a 0.1870.03 1.71 0.88 1.58 1.50
ES-EG (300 mg/kg) 1.4270,07a 0.4370.03a 2.8670.24a 0.1970.03 1.86 1.59 1.89 1.58
ES-PT (30 mg/kg) 0.8170.06 0.2570.03 1.3070.12 0.1370.01 1.06 0.92 0.86 1.08
ES-PT (100 mg/kg) 0.9070.09 0.2970.02 1.4270.06 0.1470.01 1.18 1.07 0.98 1.16
ES-PT (300 mg/kg) 0.8670.08 0.3170.04 1.2770.14 0.1370.01 1.13 1.14 0.84 1.08
ES-CC (30 mg/kg) 0.7870.06 0.2870.03 1.3870.20 0.1870.04 1.02 1.03 0.91 1.50
ES-CC (100 mg/kg) 0.7970.08 0.3070.02 1.4570.06 0.1970.02 1.03 1.11 0.96 1.58
ES-CC (300 mg/kg) 0.8270.05 0.2870.02 1.1770.17 0.1770.03 1.07 1.03 0.76 1.41
Values are expressed as mean7S. E. M. of ﬁve rats in each group in comparison with the control using one-way ANOVA followed by Dunnet test.
a po0.05.
b Saluretic index¼mmol/L problem group/mmol/L control group. El: Excreted load; HCTZ: hydrochlorothiazide.
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Tables 1 and 2 showed the urine volume and electrolyte ex-
cretion produced in 8 hours after treatment in the different ex-
perimental groups. There was no statistically signiﬁcant increaseFig. 2. ES obtained from Echinodorus grandiﬂorus induced hypotension (D–F) and increase
an intraduodenal treatment with ES-EG (30–300 mg/kg), ES-CC (30–300 mg/kg), ES-PT
were measured for 45 min after administration of distilled water (closed bars) or extrac
statistical evaluation was carried out by analysis of variance (ANOVA) followed by Dunnin urinary volume or electrolyte excretion in all animals receiving
ES-CC or ES-PT throughout the experimental period. Moreover,
acute ES-CC or ES-PT administration did not induce any signiﬁcant
changes in renal blood ﬂow when compared to animals treated
with vehicle alone (Fig. 2B and C).renal cortical blood ﬂow (A-C) in normotensive rats. The animals were subjected to
(30–300 mg/kg), or vehicle. The hypotensive and renal cortical blood ﬂow effects
ts (open bars). The results are the mean7S.E.M. of ﬁve animals in each group. The
ett’s test. apo0.05 when compared with the respective control group.
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tion while ES-CC and ES-PT do not change blood pressure in nor-
motensive rats
The basal MAP recorded in anesthetized rats after the stabili-
zation period and before the administration of any drug was
104.572.3 mm Hg. The intraduodenal administration of ES-EG
(300 mg/kg) caused a signiﬁcant reduction (15 mm Hg; po0.01)
in MAP (Fig. 2D). On the other hand, intraduodenal administration
of ES-CC or ES-PT was not able to induce any hypotensive effects
(Fig. 2E and F), with values similar to group treated with vehicle
alone. In addition, none of the extracts changed heart rate (HR)
(data not shown).
3.5. ES-EG induces antioxidative properties and nitric oxide pro-
duction in Wistar rats
In order to assess the contribution of the antioxidant properties
of ES-EG, ES-CC and ES-PT in the renal and hemodynamic re-
sponses, initial screening with three “in vitro” tests was per-
formed. Firstly, the ability of extracts to capture the DPPH free
radical was evaluated. Secondly, the potential for AAPH-induced
hemolysis inhibition was measured, and ﬁnally, their nitric oxide
radical scavenging properties were also evaluated. Data have
shown that all extracts (ES-EG, ES-CC and ES-PT) were able to
present DPPH radical scavenging activity with IC50 values esti-
mated in 10274.3, 1874.1 and 672.9 μg/mL, respectively
(Table 3).
After initial conﬁrmation of the antioxidant activity, the effect
of ES-EG, ES-CC and ES-PT on human erythrocytes was evaluated.
All tested extracts did not induce hemolysis after incubation for
240 min (Fig. 3), indicating that, at the concentrations evaluated,
the extract is not toxic to normal cells. Moreover, during the 240-
min incubation with hemolysis inducer AAPH, ES obtained from E.
grandiﬂorus showed signiﬁcant antioxidant activity protecting
cells from cell lysis at concentrations of 300 and 1000 μg/mL,
showing higher activity compared to extracts from C. carthagen-
ensis and P. tenellus (Fig. 3A–C).
IC50 and maximum activity of nitric oxide radical scavenging of
standard antioxidants and ES-EG, ES-CC and ES-PT are shown in
Table 3. Although all tested extracts show antioxidant properties,
only ES obtained from E. grandiﬂorus was able to induce maximal
inhibitory effect at around 90%, with estimated IC50 value of
90 μg/mL.
Considering the diuretic, antioxidant and hemodynamic prop-
erties of ES obtained from E. grandiﬂorus; we chose to measure the
“in vivo” concentration of a nitric oxide bioavailability marker. So,
the acute administration of ES-EG (100 and 300 mg/kg), but not
ES-CC and ES-PT, signiﬁcantly increased the serum nitrate levels
when compared to the control group (ES-EG 100: 75.674.7 μM;Table 3
IC50 and maximum activity (%) of DPPH free radical scavenging and nitric oxide
(NO) radical scavenging of standard antioxidants and the ethanol soluble fractions
(ES) from Echinodorus grandiﬂorus (ES-EG), Phyllanthus tenellus (ES-PT) and Cuphea
carthagenensis (ES-CC).
DPPH free radical scavenging NO radical scavenging
IC50
(μg/mL)
% μg/mL IC50 (μg/mL) % μg/mL
ES-EG 10274.3 9072.6 300 9872.1 9073.5 300
ES-CC 1874.1 9571.8 30 46574.1 6872.5 1000
ES-PT 672.9 9672.1 100 51272.9 6572.1 1000
Ascorbic acid 2.070.3 9773.1 10 4270.7 9575.3 100
Values are expressed as mean7S. E. M. of triplicate experiments.ES-EG 300: 88.873.9 μM; control: 50.876.6 μM; po0.05)
(Fig. 3D-F), showing that the “in vitro” antioxidant effects ob-
served with ES-EG appear also be evident in Wistar rats.4. Discussion and conclusions
There is strong evidence about the pharmacological beneﬁts of
E. grandiﬂorus, C. carthagenensis, and P. tenellus in the treatment of
various cardiovascular disorders (Braga et al., 2000; Schuldt et al.,
2000; Lessa et al., 2008). These species have been used in Brazilian
folk medicine as an adjunct to conventional treatments to produce
diuretic effects for decades (Lorenzi and Matos, 2008; Bolson et al.,
2015). Nevertheless, to the present moment, there are no studies
using a suitable experimental model, which validates their use as a
diuretic as they are used in traditional medicine. Thus, the results
obtained in this study bring to light evidence and show for ﬁrst
time that only infusion obtained from E. grandiﬂorus leaves has
effective diuretic, natriuretic and hypotensive activity on rats after
acute treatment.
It is known that drugs with diuretic action are considered as
ﬁrst choice for the treatment of hypertension, especially by in-
creasing urine ﬂow and renal sodium excretion, as well as their
important vasodilator effects (McManus et al., 2012). Currently,
the pharmaceutical market offers several treatment options of
diuretic drugs, especially loop diuretics and thiazides. Despite
their high effectiveness, adverse effects caused by continued use or
high doses of these drugs have led to a low adherence to treat-
ment. The main cause of this problem may be explained at least in
part by increased urinary elimination of electrolytes, leading to the
onset of metabolic and cardiac disorders, including metabolic
acidosis and arrhythmias. Moreover, the prolonged action of
diuretics hinders the activity of compensatory mechanisms re-
sponsible for the reabsorption of ions, generating mostly an elec-
trolyte imbalance (Ellison and Lofﬁng, 2009).
In developing this study, we propose to investigate effective
therapeutic alternatives based on ethnopharmacological validation
of various natural products. Thus, if the test substance presents a
signiﬁcant diuretic and effective natriuretic effect associated with
a small potassium and bicarbonate excretion, it could become a
promising therapeutic option with low probability of causing ad-
verse effects. To our surprise, two species widely used as diuretic
in Brazil showed no diuretic properties and do not justify its
popular use in the way they have been used for decades. On the
other hand, the infusion obtained from E. grandiﬂorus showed
acute diuretic effect, similar to that obtained with hydro-
chlorothiazide, a widely used thiazide diuretic. In this study, hy-
drochlorothiazide at a dose of 25 mg/kg showed high effective-
ness, but eliminated large amounts of potassium and bicarbonate
in the urine. Currently, it is known that thiazides exert their
diuretic effect through inhibition of the Naþ/Cl co-transporter in
the tubular distal convoluted, causing a signiﬁcant retention of
NaCl in the renal tubules that provides a large excretion of water,
chloride, sodium and potassium. Moreover, some members of this
group retain signiﬁcant carbonic anhydrase inhibitory activity
(Jackson, 1996). Although the effects of ES-EG on urine volume,
sodium, potassium, and chloride excretion was similar to that
obtained with hydrochlorothiazide, a signiﬁcant difference in re-
lation to bicarbonate excretion was observed, showing a sig-
niﬁcant sparing effect of this ion.
Although the results obtained are very signiﬁcant, it remains
unclear through which mechanisms ES-EG exerts its diuretic ef-
fects. In recent years, several studies have been published about
the pharmacologic mechanisms that form the basis of the diuretic
properties of various natural products. Many medicinal plants and
their secondary metabolites such as ﬂavonoids and condensed
Fig. 3. ES obtained from Echinodorus grandiﬂorus protects against lipid peroxidation “in vitro” (A–C) and increases serum nitrate levels (D–F) in Wistar rats. The serum was
obtained after 8 hours of treatment. The results are the mean7S.E.M. of ﬁve animals in each group or “in vitro” experiments performed in triplicate. The statistical
evaluation was carried out by analysis of variance (ANOVA) followed by Dunnett’s test. apo0.05 when compared with the respective control group (D) or negative control
group (A–C) (erythrocytes with saline). bpo0.05 when compared with the positive control group (A–C) (erythrocytes with AAPH).
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including ACE inhibition and bradykinin receptor activation with
subsequent release of endothelial nitric oxide and prostaglandins
(Gasparotto Junior et al., 2009; 2012;Leme et al., 2013). Moreover,
some effects on vasopressin release (Kazama et al., 2012) and os-
motic properties have been described, primarily due to the oc-
currence of large amounts of metals in the parenchyma of several
herbal medicines (Benjumea et al., 2005). It is too premature for us
to suggest any mechanism of action of ES-EG, and other in-depth
studies should be conducted for this purpose. On the other hand,
the large electrolyte excretion induced by species is not char-
acteristic of drugs that inhibit the release of vasopressin, and the
small amount of metal naturally found in E. grandiﬂorus leaves
(data not shown) can exclude a probable osmotic effect. Further-
more, although other studies have shown “in vitro” ACE inhibitor
effects of different extract obtained from these species, no
“in vivo” effect on this enzyme were observed in this study, ex-
cluding a probable effect related to this mechanism.
When the diuretic effects induced by ES-EG are observed, it
was found that the major components found in this infusion and
that could be the agents responsible for this activity are several
ﬂavonoids C-glycosides including swertisin, isovitexin, isoorientin,
swertiajaponin, and their diglycoside derivatives. In recent years,
studies have shown the role played by ﬂavonoids in reducing andpreventing the formation of free radicals and other oxidizing
agents. In addition, these compounds were closely related with
diuretic, antihypertensive and antiatherosclerotic activity of sev-
eral natural products (Gasparotto Junior et al., 2011, 2012; Brant
et al., 2014).
As phenolic compounds are classical antioxidant agents, and
this effect could increase the bioavailability of endothelial nitric
oxide leading to dilatation of the renal afferent arterioles and in-
creasing glomerular ﬁltration rate (Gasparotto Junior et al., 2012),
we chose to perform an initial screening using three classic “in
vitro” antioxidant tests. So, all infusions tested (ES-EG, ES-CC, and
ES-PT) were able to promote a strong (“in vitro”) antioxidant ac-
tivity in the three models used. On the other hand, only ES-EG was
able to increase the bioavailability of endothelial nitric oxide
(measured by serum nitrate), with possible effects in systemic and
renal vasculature. In fact, an important increase in renal cortical
blood ﬂow was observed, which could inﬂuence the glomerular
ﬁltration rate and induce diuresis. Moreover, as previously re-
ported with another extraction process and different administra-
tion route (Lessa et al., 2008), a signiﬁcantly acute hypotensive
effect was also observed, without affecting heart rate after in-
traduodenal administration. Further pharmacological studies
should be carried out in order to investigate the molecular me-
chanisms involved in diuretic and hypotensive effects of ES-EG and
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of this extract in renal and hemodynamic effects.
In summary, the results presented here shown that the ES-EG
obtained from E. grandiﬂorus leaves shown a signiﬁcant diuretic
and hypotensive activity and suggest that these effects could be
related with an important renal and systemic vasodilator effect. In
addition, it was shown for the ﬁrst time that the pharmacological
effects of ethanol soluble fractions obtained from P. tenellus and C.
carthagenensis do not support their popular use as a diuretic agent.
However, since the isolated compounds of these species are po-
tentially promising as pharmacological agents, future studies
should elucidate the probable pharmacological mechanisms cul-
turally assigned to these plants.Acknowledgments
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